These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 15145690

  • 1. Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
    Margenthaler JA, Kataoka M, Flye WM.
    J Surg Res; 2004 Jun 15; 119(2):107-12. PubMed ID: 15145690
    [Abstract] [Full Text] [Related]

  • 2. CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction.
    Margenthaler JA, Landeros K, Kataoka M, Flye MW.
    J Surg Res; 2002 May 01; 104(1):29-35. PubMed ID: 11971674
    [Abstract] [Full Text] [Related]

  • 3. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA, Flye MW.
    Surgery; 2005 Aug 01; 138(2):141-9. PubMed ID: 16153420
    [Abstract] [Full Text] [Related]

  • 4. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells.
    Fujiwara H, Qian JH, Satoh S, Kokudo S, Ikegami R, Hamaoka T.
    J Immunol; 1986 Apr 15; 136(8):2763-8. PubMed ID: 2420865
    [Abstract] [Full Text] [Related]

  • 5. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.
    Smith LM, Bonafonte MT, Campbell LD, Mead JR.
    Exp Parasitol; 2001 Jul 15; 98(3):123-33. PubMed ID: 11527435
    [Abstract] [Full Text] [Related]

  • 6. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.
    Qian J, Hashimoto T, Fujiwara H, Hamaoka T.
    J Immunol; 1985 Jun 15; 134(6):3656-61. PubMed ID: 2580893
    [Abstract] [Full Text] [Related]

  • 7. Gamma delta TCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo.
    Gorczynski RM, Cohen Z, Leung Y, Chen Z.
    J Immunol; 1996 Jul 15; 157(2):574-81. PubMed ID: 8752904
    [Abstract] [Full Text] [Related]

  • 8. Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route.
    Sato S, Qian JH, Kokudo S, Ikegami R, Suda T, Hamaoka T, Fujiwara H.
    J Immunol; 1988 Feb 01; 140(3):717-22. PubMed ID: 2448373
    [Abstract] [Full Text] [Related]

  • 9. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
    Yamada J, Hamuro J, Fukushima A, Ohteki T, Terai K, Iwakura Y, Yagita H, Kinoshita S.
    Invest Ophthalmol Vis Sci; 2009 May 01; 50(5):2139-46. PubMed ID: 19136699
    [Abstract] [Full Text] [Related]

  • 10. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.
    Surgery; 2009 Jun 01; 145(6):663-74. PubMed ID: 19486771
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA, Landeros K, Kataoka M, Flye MW.
    Transpl Immunol; 2003 Jun 01; 11(1):23-9. PubMed ID: 12727472
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: possible explanation for the mechanism of tolerance induction by portal vein injection.
    Zhang Y, Yasumizu R, Sugiura K, Hashimoto F, Amoh Y, Lian Z, Cherry, Nishio N, Ikehara S.
    Eur J Immunol; 1994 Jul 01; 24(7):1558-65. PubMed ID: 7913037
    [Abstract] [Full Text] [Related]

  • 15. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
    Sugiura K, Kato K, Hashimoto F, Jin T, Amoh Y, Yamamoto Y, Morita H, Okumura K, Ikehara S.
    Immunobiology; 1997 Nov 01; 197(5):460-77. PubMed ID: 9413746
    [Abstract] [Full Text] [Related]

  • 16. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
    Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, Gazzinelli RT, Sher A.
    J Immunol; 1996 Nov 01; 157(9):4045-54. PubMed ID: 8892638
    [Abstract] [Full Text] [Related]

  • 17. CD4 Th2 cells do not functionally suppress CTL generation in neonatal tolerant mice.
    Gao Q, Chen N, Field EH.
    Transplantation; 1995 Dec 15; 60(11):1260-8. PubMed ID: 8525520
    [Abstract] [Full Text] [Related]

  • 18. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J, Liu J, Xie S.
    Zhonghua Yi Xue Za Zhi; 2001 May 25; 81(10):593-6. PubMed ID: 11798930
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Taniguchi T, Liu FT, Ueno H.
    Exp Eye Res; 2006 Feb 25; 82(2):210-8. PubMed ID: 16102751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.